Company profile
Rapid Micro Biosystems, Inc.
NASDAQ: RPID · Healthcare · Medical - Devices
#487 of 1,422 Healthcare companies by revenue66th-percentile growth
EA Score
46DFH 38DQ 46GM 69SS 50
v0.1 · 65/100 weight · provisional
↑ 3-yr revenue growth, workforce scale · ↓ listing tenure, Piotroski F
Methodology →Revenue TTM
$34.4M
Rev growth YoY (TTM)
+16.0%
Net income (FY)
-$47.1M
Employees
171
as of 2026-08-18
Market cap
$71.2M
as of 2026-08-18
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$33.6M$33.6M2025
Net income-$47.1M-$47.1M2025
Operating income-$47.4M-$47.4M2025
Total assets$74.9M$74.9M2025
Liabilities$41.6M$41.6M2025
Equity$33.2M$33.2M2025
Revenue trend
FY2021 – FY2025 · USD
FY21
FY21
FY22
FY23
FY24
FY25
Revenue by segment
Filed disclosures · FY2025
By product
Product72%
Service28%
By geography
UNITED STATES40%
SWITZERLAND18%
All Other Countries17%
GERMANY17%
JAPAN8%
The read
What is Rapid Micro Biosystems, Inc.’s revenue?
Rapid Micro Biosystems, Inc. booked $33.6M in FY2025 revenue, growing 20% year over year — faster than most Healthcare companies we track, at a -140.3% net margin.
Peers · Healthcare
Senseonics Holdings, Inc.57CX4 Pharmaceuticals, Inc.51DPrecision BioSciences, Inc.46DOrchestra BioMed Holdings, Inc.46DArcus Biosciences, Inc.47DC21 Investments Inc.49DNeighbors
Middlesex →Key facts
CEORobert G. Spignesi Jr.
SectorHealthcare
IndustryMedical - Devices
HeadquartersLowell, MA
ExchangeNASDAQ: RPID
Employees171
IPO date2021-07-15
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.